Literature DB >> 19680683

Lysophosphatidylcholine- and MCP-1-induced chemotaxis of monocytes requires potassium channel activity.

Tom Schilling1, Claudia Eder.   

Abstract

One of the earliest cellular responses in atherogenesis is the focal recruitment of circulating monocytes, while the most important atherogenic chemoattractants are monocyte chemoattractant protein-1 (MCP-1) and lysophosphatidylcholine (LPC). Invading monocytes transform into activated macrophages and foam cells, which stimulate inflammatory processes and promote atherosclerosis. In this study, we have searched for common mechanisms involved in MCP-1- and LPC-stimulated monocyte migration. We have found that migration of THP-1 monocytes stimulated with MCP-1 was reduced upon inhibition of G(i/o) proteins with pertussis toxin and upon inhibition of platelet activating factor receptors with BN52021, whereas LPC-stimulated monocyte chemotaxis remained unaffected by both inhibitors. Furthermore, Cl(-) channels were only required for MCP-1-induced chemotaxis. However, activity of voltage-gated K+ channels and of Ca2+-activated K+ channels was found to be involved in migration of monocytes stimulated with either MCP-1 or LPC. Inhibition of voltage-gated K+ channels with 4-aminopyridine or margatoxin partially inhibited MCP-1- and LPC-stimulated migration of monocytes. Blockade of Ca2+-activated K+ channels with TRAM-34 also partially reduced migration of MCP-1- and LPC-stimulated monocytes. Simultaneous inhibition of voltage-gated and Ca2+-activated K+ channels abolished MCP-1- and LPC-induced chemotaxis of monocytes. Thus, K+ channel inhibition may represent a novel powerful strategy to reduce monocyte infiltration and subsequent inflammation in atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19680683     DOI: 10.1007/s00424-009-0710-y

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  29 in total

Review 1.  The immune response in atherosclerosis: a double-edged sword.

Authors:  Göran K Hansson; Peter Libby
Journal:  Nat Rev Immunol       Date:  2006-06-16       Impact factor: 53.106

2.  Lysophosphatidylcholine stimulates phospholipase D activity in mouse peritoneal macrophages.

Authors:  A Gómez-Muñoz; L O'Brien; R Hundal; U P Steinbrecher
Journal:  J Lipid Res       Date:  1999-06       Impact factor: 5.922

3.  Polarized ion transport during migration of transformed Madin-Darby canine kidney cells.

Authors:  A Schwab; K Gabriel; F Finsterwalder; G Folprecht; R Greger; A Kramer; H Oberleithner
Journal:  Pflugers Arch       Date:  1995-09       Impact factor: 3.657

4.  Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis.

Authors:  M T Quinn; S Parthasarathy; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

Review 5.  Involvement of chemokine receptor 2 and its ligand, monocyte chemoattractant protein-1, in the development of atherosclerosis: lessons from knockout mice.

Authors:  W Peters; I F Charo
Journal:  Curr Opin Lipidol       Date:  2001-04       Impact factor: 4.776

6.  TRAM-34 inhibits nonselective cation channels.

Authors:  Tom Schilling; Claudia Eder
Journal:  Pflugers Arch       Date:  2007-02-23       Impact factor: 3.657

Review 7.  Voltage-gated potassium channels in multiple sclerosis: Overview and new implications for treatment of central nervous system inflammation and degeneration.

Authors:  Susan I V Judge; Jennifer M Lee; Christopher T Bever; Paul M Hoffman
Journal:  J Rehabil Res Dev       Date:  2006 Jan-Feb

8.  Physical principles underlying the transduction of bilayer deformation forces during mechanosensitive channel gating.

Authors:  Eduardo Perozo; Anna Kloda; D Marien Cortes; Boris Martinac
Journal:  Nat Struct Biol       Date:  2002-09

9.  Gi-independent macrophage chemotaxis to lysophosphatidylcholine via the immunoregulatory GPCR G2A.

Authors:  Li V Yang; Caius G Radu; Li Wang; Mireille Riedinger; Owen N Witte
Journal:  Blood       Date:  2004-09-21       Impact factor: 22.113

Review 10.  Inflammation and atherosclerosis.

Authors:  Göran K Hansson; Anna-Karin L Robertson; Cecilia Söderberg-Nauclér
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

View more
  6 in total

1.  The calcium-activated potassium channel KCa3.1 plays a central role in the chemotactic response of mammalian neutrophils.

Authors:  C Henríquez; T T Riquelme; D Vera; F Julio-Kalajzić; P Ehrenfeld; J E Melvin; C D Figueroa; J Sarmiento; C A Flores
Journal:  Acta Physiol (Oxf)       Date:  2015-07-19       Impact factor: 6.311

2.  Prevention of 1-palmitoyl lysophosphatidylcholine-induced inflammation by polyunsaturated acyl lysophosphatidylcholine.

Authors:  Nguyen Dang Hung; Dai-Eun Sok; Mee Ree Kim
Journal:  Inflamm Res       Date:  2012-01-18       Impact factor: 4.575

3.  The GPR55 agonist lysophosphatidylinositol directly activates intermediate-conductance Ca2+ -activated K+ channels.

Authors:  Alexander I Bondarenko; Roland Malli; Wolfgang F Graier
Journal:  Pflugers Arch       Date:  2011-05-21       Impact factor: 3.657

4.  KCa3.1 K+ Channel Expression and Function in Human Bronchial Epithelial Cells.

Authors:  Greer K Arthur; S Mark Duffy; Katy M Roach; Rob A Hirst; Aarti Shikotra; Erol A Gaillard; Peter Bradding
Journal:  PLoS One       Date:  2015-12-21       Impact factor: 3.240

5.  Pleiotropic Effects of Simvastatin on the Regulation of Potassium Channels in Monocytes.

Authors:  Shaoping Wang; Yuhua Ran; Xuejun Chen; Chungang Li; Shujuan Cheng; Jinghua Liu
Journal:  Front Pharmacol       Date:  2020-02-21       Impact factor: 5.810

6.  The Synthetic Dipeptide Pidotimod Shows a Chemokine-Like Activity through CXC Chemokine Receptor 3 (CXCR3).

Authors:  Francesca Caccuri; Antonella Bugatti; Silvia Corbellini; Sara Roversi; Alberto Zani; Pietro Mazzuca; Stefania Marsico; Arnaldo Caruso; Cinzia Giagulli
Journal:  Int J Mol Sci       Date:  2019-10-24       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.